Integumen PLC Cooperative Alliance; Trading Update (3838A)
21 Enero 2020 - 1:00AM
UK Regulatory
TIDMSKIN
RNS Number : 3838A
Integumen PLC
21 January 2020
AIM share code: SKIN
21 January 2020
Integumen PLC
("Integumen" or "Company")
Integumen signs cooperative alliance MOU with Innocare Group,
Shanghai, China
Trading update: Unaudited Revenues up 366% to GBP1m,
Integumen's subsidiary Labskin today announces that it has
signed a Memorandum of Understanding with Innocare Group. The
cooperative alliance has been established to promote innovation and
cooperation between research institutions that will assist
commercial enterprises in China with routes to regulatory
compliance using Labskin and LabskinAI without the need for animal
testing for cosmetics and skincare products.
Post Year-End 2019 Trading Update:
Even with 6 weeks' delay in opening up the new laboratories in
York, UK, demand for Labskin and LabskinAI services mean that
following the end of the financial year, Integumen has achieved the
7-figure turnover number (unaudited) we had anticipated. Unaudited
figures show that revenues increased 366% to GBP1.004m (2018:
GBP0.274m - audited) including GBP0.178m relating to Rinocloud in
the period pre-acquisition on 2 May 2019)
Gerard Brandon, CEO of Integumen, comments:
"Following a very successful year in 2019, Integumen has started
2020 as the "No.#1 Thought Leader on Skin Microbiome and AI". We
have a strong global Top 20 cosmetic and skin care client base and
with the signing of this MOU with the Innocare Group, a foothold
into the fast-growing Chinese market. Our sales, including
recurring revenues, look set to continue strong triple digit growth
as our order book of existing and new clients expands across three
continents."
Charles Xu, President and CEO of Innocare Group, added:
"We are delighted to be collaborating with Labskin and
immediately recognise that our combined expertise, technologies and
access to R&D in China and Europe will achieve far more and
enable faster commercialisation for our respective technologies on
both continents."
Contacts
+44 (0) 7340 055
Integumen plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
---------------------------- -----------------
Turner Pope Investments (TPI) +44 (0) 20 3657
Limited (Broker) Andy Thacker/Zoe Alexander 0050
---------------------------- -----------------
About Integumen: www.integumen.com
Integumen is a vertically integrated product and services
company for skin related diseases, treatments and therapies with
four business units:
-- Labskin AI's technology platform incorporates artificial
intelligence within clinical research for medical device,
pharmaceuticals, cosmeceuticals and related life science test
services. Labskin allows skincare, healthcare, pharmaceutical
manufacturers and cosmetic companies to test their products on
human-like skin in a real-world environment with full access to
multiple state-of-the-art partner technologies.
-- Rinodrive is a data aggregation, refining and AI analysis
open-source eco-system designed to provide third-party service
providers the ability to offer their clients valuable insights that
support clinical, operational and financial decisions in healthcare
services, third-level education, government departments and the
financial sector.
-- Wound pHase is developing skin and wound care products using
its proprietary wound dressing technology. Working in collaboration
with CBD providers creating a CBD infused diabetic wound care
product range.
-- Stoer-for-men skin products e-commerce division offers a
range of skincare products derived from 5 natural super-ingredient
plant extracts specifically for men to reduce the signs of ageing
and is also used as a control for client testing within Labskin
laboratories.
About the Innocare Group: : (www.labcaregroup.com)
Labcare Scientific International, for 10 years, has been a
leading scientific instrument, equipment and supplies company
serving todays laboratory needs with innovative products from
around the world.
Partnering with and supporters of the Shanghai Hi-Tech
International Development Program, they actively participate
internationally to bridge the innovation gap between China and the
Rest of the World for technologies in Healthcare, Biotech, Internet
of Things.
Since 2017 they have participated in the annual European forum
"Beyond IoT" held in the Nimbus Research Centre, Cork, Ireland and
for the first time Innocare Group will host the "Beyond IoT" Forum
in China in 2020.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTBMMLTMTJTBJM
(END) Dow Jones Newswires
January 21, 2020 02:00 ET (07:00 GMT)
Integumen (LSE:SKIN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Integumen (LSE:SKIN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024